#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4.
1-1	0-2	4.	_	_	_	_

#Text=Discussion and Conclusions
2-1	3-13	Discussion	abstract	new	_	_
2-2	14-17	and	_	_	_	_
2-3	18-29	Conclusions	abstract	new	_	_

#Text=In this study , we considered the following two major factors that could influence the evolution of the f8/9 landscape phage library in mice : ( 1 ) its multidisperse characteristics as revealed in soft agar electrophoresis and ( 2 ) organ- and tumor-specific targets for phage binding interactions that can arise from organ- or tissue-specific gene expression .
3-1	30-32	In	_	_	_	_
3-2	33-37	this	abstract[3]	new[3]	coref	5-4[34_3]
3-3	38-43	study	abstract[3]	new[3]	_	_
3-4	44-45	,	_	_	_	_
3-5	46-48	we	person	acc	ana	4-1
3-6	49-59	considered	_	_	_	_
3-7	60-63	the	abstract[5]	new[5]	_	_
3-8	64-73	following	abstract[5]	new[5]	_	_
3-9	74-77	two	abstract[5]	new[5]	_	_
3-10	78-83	major	abstract[5]	new[5]	_	_
3-11	84-91	factors	abstract[5]	new[5]	_	_
3-12	92-96	that	abstract[5]	new[5]	_	_
3-13	97-102	could	abstract[5]	new[5]	_	_
3-14	103-112	influence	abstract[5]	new[5]	_	_
3-15	113-116	the	abstract[5]|event[6]	new[5]|new[6]	coref	15-8[0_6]
3-16	117-126	evolution	abstract[5]|event[6]	new[5]|new[6]	_	_
3-17	127-129	of	abstract[5]|event[6]	new[5]|new[6]	_	_
3-18	130-133	the	abstract[5]|event[6]|abstract[9]	new[5]|new[6]|new[9]	ana	3-29[0_9]
3-19	134-138	f8/9	abstract[5]|event[6]|abstract|abstract[9]	new[5]|new[6]|new|new[9]	_	_
3-20	139-148	landscape	abstract[5]|event[6]|abstract[9]	new[5]|new[6]|new[9]	_	_
3-21	149-154	phage	abstract[5]|event[6]|place|abstract[9]	new[5]|new[6]|new|new[9]	coref	3-47
3-22	155-162	library	abstract[5]|event[6]|abstract[9]	new[5]|new[6]|new[9]	_	_
3-23	163-165	in	abstract[5]|event[6]|abstract[9]	new[5]|new[6]|new[9]	_	_
3-24	166-170	mice	abstract[5]|event[6]|abstract[9]|animal	new[5]|new[6]|new[9]|new	_	_
3-25	171-172	:	_	_	_	_
3-26	173-174	(	_	_	_	_
3-27	175-176	1	_	_	_	_
3-28	177-178	)	_	_	_	_
3-29	179-182	its	abstract|abstract[12]	giv|new[12]	coref	17-29[184_0]
3-30	183-196	multidisperse	abstract[12]	new[12]	_	_
3-31	197-212	characteristics	abstract[12]	new[12]	_	_
3-32	213-215	as	abstract[12]	new[12]	_	_
3-33	216-224	revealed	abstract[12]	new[12]	_	_
3-34	225-227	in	abstract[12]	new[12]	_	_
3-35	228-232	soft	abstract[12]|substance[13]|object[14]	new[12]|new[13]|new[14]	_	_
3-36	233-237	agar	abstract[12]|substance[13]|object[14]	new[12]|new[13]|new[14]	_	_
3-37	238-253	electrophoresis	abstract[12]|object[14]	new[12]|new[14]	_	_
3-38	254-257	and	_	_	_	_
3-39	258-259	(	_	_	_	_
3-40	260-261	2	_	_	_	_
3-41	262-263	)	_	_	_	_
3-42	264-270	organ-	abstract[15]	new[15]	_	_
3-43	271-274	and	abstract[15]	new[15]	_	_
3-44	275-289	tumor-specific	abstract[15]	new[15]	_	_
3-45	290-297	targets	abstract[15]	new[15]	_	_
3-46	298-301	for	abstract[15]	new[15]	_	_
3-47	302-307	phage	abstract[15]|place|object[17]|abstract[18]	new[15]|giv|new[17]|new[18]	coref|coref|coref	4-17|4-32[30_18]|7-36[0_17]
3-48	308-315	binding	abstract[15]|object[17]|abstract[18]	new[15]|new[17]|new[18]	_	_
3-49	316-328	interactions	abstract[15]|abstract[18]	new[15]|new[18]	_	_
3-50	329-333	that	abstract[15]|abstract[18]	new[15]|new[18]	_	_
3-51	334-337	can	abstract[15]|abstract[18]	new[15]|new[18]	_	_
3-52	338-343	arise	abstract[15]|abstract[18]	new[15]|new[18]	_	_
3-53	344-348	from	abstract[15]|abstract[18]	new[15]|new[18]	_	_
3-54	349-355	organ-	abstract[15]|abstract[18]|abstract[20]	new[15]|new[18]|new[20]	coref	15-19[158_20]
3-55	356-358	or	abstract[15]|abstract[18]|abstract[20]	new[15]|new[18]|new[20]	_	_
3-56	359-374	tissue-specific	abstract[15]|abstract[18]|abstract[20]	new[15]|new[18]|new[20]	_	_
3-57	375-379	gene	abstract[15]|abstract[18]|abstract|abstract[20]	new[15]|new[18]|new|new[20]	coref	15-20
3-58	380-390	expression	abstract[15]|abstract[18]|abstract[20]	new[15]|new[18]|new[20]	_	_
3-59	391-392	.	_	_	_	_

#Text=We showed that modified p8 proteins displaying a fusion peptide along the length of the filamentous phage particle would create vastly different particles , each containing unique physicochemical features and supporting complex interactions within a defined microenvironment .
4-1	393-395	We	person	giv	ana	5-4
4-2	396-402	showed	_	_	_	_
4-3	403-407	that	_	_	_	_
4-4	408-416	modified	substance[23]	new[23]	coref	16-15[168_23]
4-5	417-419	p8	abstract|substance[23]	new|new[23]	_	_
4-6	420-428	proteins	substance[23]	new[23]	_	_
4-7	429-439	displaying	substance[23]	new[23]	_	_
4-8	440-441	a	substance[23]|substance[24]	new[23]|new[24]	coref	6-28[64_24]
4-9	442-448	fusion	substance[23]|substance[24]	new[23]|new[24]	_	_
4-10	449-456	peptide	substance[23]|substance[24]	new[23]|new[24]	_	_
4-11	457-462	along	substance[23]	new[23]	_	_
4-12	463-466	the	substance[23]|abstract[25]	new[23]|new[25]	_	_
4-13	467-473	length	substance[23]|abstract[25]	new[23]|new[25]	_	_
4-14	474-476	of	substance[23]|abstract[25]	new[23]|new[25]	_	_
4-15	477-480	the	substance[23]|abstract[25]|object[27]	new[23]|new[25]|new[27]	coref	5-32[46_27]
4-16	481-492	filamentous	substance[23]|abstract[25]|object[27]	new[23]|new[25]|new[27]	_	_
4-17	493-498	phage	substance[23]|abstract[25]|place|object[27]	new[23]|new[25]|giv|new[27]	coref	5-33
4-18	499-507	particle	substance[23]|abstract[25]|object[27]	new[23]|new[25]|new[27]	_	_
4-19	508-513	would	_	_	_	_
4-20	514-520	create	_	_	_	_
4-21	521-527	vastly	object[28]	new[28]	coref	7-20[75_28]
4-22	528-537	different	object[28]	new[28]	_	_
4-23	538-547	particles	object[28]	new[28]	_	_
4-24	548-549	,	object[28]	new[28]	_	_
4-25	550-554	each	object[28]	new[28]	_	_
4-26	555-565	containing	object[28]	new[28]	_	_
4-27	566-572	unique	object[28]|abstract[29]	new[28]|new[29]	coref	18-73[208_29]
4-28	573-588	physicochemical	object[28]|abstract[29]	new[28]|new[29]	_	_
4-29	589-597	features	object[28]|abstract[29]	new[28]|new[29]	_	_
4-30	598-601	and	object[28]	new[28]	_	_
4-31	602-612	supporting	object[28]	new[28]	_	_
4-32	613-620	complex	object[28]|abstract[30]	new[28]|giv[30]	coref	21-11[218_30]
4-33	621-633	interactions	object[28]|abstract[30]	new[28]|giv[30]	_	_
4-34	634-640	within	_	_	_	_
4-35	641-642	a	abstract[31]	new[31]	coref	7-11[71_31]
4-36	643-650	defined	abstract[31]	new[31]	_	_
4-37	651-667	microenvironment	abstract[31]	new[31]	_	_
4-38	668-669	.	_	_	_	_

#Text=As reflected in our in vitro migration study , the presence of random fusion peptides with charged amino acids in landscape phages results in significant changes in the ionization state of the phage particle leading to differences in surface charge and their subsequent ability to migrate through an agarose gel , demonstrated previously with isolated clones .
5-1	670-672	As	_	_	_	_
5-2	673-682	reflected	_	_	_	_
5-3	683-685	in	_	_	_	_
5-4	686-689	our	person|abstract[34]	giv|giv[34]	coref|ana	8-2[83_34]|9-20
5-5	690-692	in	abstract[34]	giv[34]	_	_
5-6	693-698	vitro	abstract[34]	giv[34]	_	_
5-7	699-708	migration	abstract|abstract[34]	new|giv[34]	_	_
5-8	709-714	study	abstract[34]	giv[34]	_	_
5-9	715-716	,	_	_	_	_
5-10	717-720	the	abstract[35]	new[35]	_	_
5-11	721-729	presence	abstract[35]	new[35]	_	_
5-12	730-732	of	abstract[35]	new[35]	_	_
5-13	733-739	random	abstract[35]|substance[37]	new[35]|new[37]	_	_
5-14	740-746	fusion	abstract[35]|abstract|substance[37]	new[35]|new|new[37]	coref	6-30
5-15	747-755	peptides	abstract[35]|substance[37]	new[35]|new[37]	_	_
5-16	756-760	with	abstract[35]|substance[37]	new[35]|new[37]	_	_
5-17	761-768	charged	abstract[35]|substance[37]|substance[39]	new[35]|new[37]|new[39]	_	_
5-18	769-774	amino	abstract[35]|substance[37]|object|substance[39]	new[35]|new[37]|new|new[39]	_	_
5-19	775-780	acids	abstract[35]|substance[37]|substance[39]	new[35]|new[37]|new[39]	_	_
5-20	781-783	in	abstract[35]	new[35]	_	_
5-21	784-793	landscape	abstract[35]|abstract|animal[41]	new[35]|new|new[41]	ana|coref	5-42[0_41]|6-7
5-22	794-800	phages	abstract[35]|animal[41]	new[35]|new[41]	_	_
5-23	801-808	results	_	_	_	_
5-24	809-811	in	_	_	_	_
5-25	812-823	significant	abstract[42]	new[42]	coref	7-6[68_42]
5-26	824-831	changes	abstract[42]	new[42]	_	_
5-27	832-834	in	abstract[42]	new[42]	_	_
5-28	835-838	the	abstract[42]|abstract[44]	new[42]|new[44]	_	_
5-29	839-849	ionization	abstract[42]|abstract|abstract[44]	new[42]|new|new[44]	_	_
5-30	850-855	state	abstract[42]|abstract[44]	new[42]|new[44]	_	_
5-31	856-858	of	abstract[42]|abstract[44]	new[42]|new[44]	_	_
5-32	859-862	the	abstract[42]|abstract[44]|object[46]	new[42]|new[44]|giv[46]	coref	6-39[66_46]
5-33	863-868	phage	abstract[42]|abstract[44]|place|object[46]	new[42]|new[44]|giv|giv[46]	coref	7-21
5-34	869-877	particle	abstract[42]|abstract[44]|object[46]	new[42]|new[44]|giv[46]	_	_
5-35	878-885	leading	abstract[42]	new[42]	_	_
5-36	886-888	to	abstract[42]	new[42]	_	_
5-37	889-900	differences	abstract[42]|abstract[47]	new[42]|new[47]	_	_
5-38	901-903	in	abstract[42]|abstract[47]	new[42]|new[47]	_	_
5-39	904-911	surface	abstract[42]|abstract[47]|place|abstract[49]	new[42]|new[47]|new|new[49]	coref|coref	7-17|7-16[73_49]
5-40	912-918	charge	abstract[42]|abstract[47]|abstract[49]	new[42]|new[47]|new[49]	_	_
5-41	919-922	and	abstract[42]|abstract[47]	new[42]|new[47]	_	_
5-42	923-928	their	abstract[42]|abstract[47]|animal|abstract[51]	new[42]|new[47]|giv|new[51]	coref|coref	6-7[57_0]|6-25[62_51]
5-43	929-939	subsequent	abstract[42]|abstract[47]|abstract[51]	new[42]|new[47]|new[51]	_	_
5-44	940-947	ability	abstract[42]|abstract[47]|abstract[51]	new[42]|new[47]|new[51]	_	_
5-45	948-950	to	abstract[42]|abstract[47]|abstract[51]	new[42]|new[47]|new[51]	_	_
5-46	951-958	migrate	abstract[42]|abstract[47]|abstract[51]	new[42]|new[47]|new[51]	_	_
5-47	959-966	through	abstract[42]|abstract[47]|abstract[51]	new[42]|new[47]|new[51]	_	_
5-48	967-969	an	abstract[42]|abstract[47]|abstract[51]|object[53]	new[42]|new[47]|new[51]|new[53]	_	_
5-49	970-977	agarose	abstract[42]|abstract[47]|abstract[51]|abstract|object[53]	new[42]|new[47]|new[51]|new|new[53]	_	_
5-50	978-981	gel	abstract[42]|abstract[47]|abstract[51]|object[53]	new[42]|new[47]|new[51]|new[53]	_	_
5-51	982-983	,	_	_	_	_
5-52	984-996	demonstrated	_	_	_	_
5-53	997-1007	previously	_	_	_	_
5-54	1008-1012	with	_	_	_	_
5-55	1013-1021	isolated	abstract[54]	new[54]	_	_
5-56	1022-1028	clones	abstract[54]	new[54]	_	_
5-57	1029-1030	.	_	_	_	_

#Text=This unique , emergent feature of landscape phages cannot be translated to p3-type libraries as the occurrence of p3 in only five copies limits the ability of a displayed fusion peptide to significantly change the physicochemical properties of the entire particle .
6-1	1031-1035	This	abstract[55]	new[55]	_	_
6-2	1036-1042	unique	abstract[55]	new[55]	_	_
6-3	1043-1044	,	abstract[55]	new[55]	_	_
6-4	1045-1053	emergent	abstract[55]	new[55]	_	_
6-5	1054-1061	feature	abstract[55]	new[55]	_	_
6-6	1062-1064	of	abstract[55]	new[55]	_	_
6-7	1065-1074	landscape	abstract[55]|abstract|animal[57]	new[55]|giv|giv[57]	coref|coref	15-11|15-11[155_57]
6-8	1075-1081	phages	abstract[55]|animal[57]	new[55]|giv[57]	_	_
6-9	1082-1088	cannot	_	_	_	_
6-10	1089-1091	be	_	_	_	_
6-11	1092-1102	translated	_	_	_	_
6-12	1103-1105	to	_	_	_	_
6-13	1106-1113	p3-type	abstract[58]	new[58]	coref	9-3[97_58]
6-14	1114-1123	libraries	abstract[58]	new[58]	_	_
6-15	1124-1126	as	_	_	_	_
6-16	1127-1130	the	event[59]	new[59]	_	_
6-17	1131-1141	occurrence	event[59]	new[59]	_	_
6-18	1142-1144	of	event[59]	new[59]	_	_
6-19	1145-1147	p3	event[59]|abstract	new[59]|new	_	_
6-20	1148-1150	in	event[59]	new[59]	_	_
6-21	1151-1155	only	event[59]|object[61]	new[59]|new[61]	_	_
6-22	1156-1160	five	event[59]|object[61]	new[59]|new[61]	_	_
6-23	1161-1167	copies	event[59]|object[61]	new[59]|new[61]	_	_
6-24	1168-1174	limits	_	_	_	_
6-25	1175-1178	the	abstract[62]	giv[62]	ana	7-1[0_62]
6-26	1179-1186	ability	abstract[62]	giv[62]	_	_
6-27	1187-1189	of	abstract[62]	giv[62]	_	_
6-28	1190-1191	a	abstract[62]|substance[64]	giv[62]|giv[64]	coref	9-7[0_64]
6-29	1192-1201	displayed	abstract[62]|substance[64]	giv[62]|giv[64]	_	_
6-30	1202-1208	fusion	abstract[62]|abstract|substance[64]	giv[62]|giv|giv[64]	_	_
6-31	1209-1216	peptide	abstract[62]|substance[64]	giv[62]|giv[64]	_	_
6-32	1217-1219	to	_	_	_	_
6-33	1220-1233	significantly	_	_	_	_
6-34	1234-1240	change	_	_	_	_
6-35	1241-1244	the	abstract[65]	new[65]	_	_
6-36	1245-1260	physicochemical	abstract[65]	new[65]	_	_
6-37	1261-1271	properties	abstract[65]	new[65]	_	_
6-38	1272-1274	of	abstract[65]	new[65]	_	_
6-39	1275-1278	the	abstract[65]|object[66]	new[65]|giv[66]	coref	8-31[0_66]
6-40	1279-1285	entire	abstract[65]|object[66]	new[65]|giv[66]	_	_
6-41	1286-1294	particle	abstract[65]|object[66]	new[65]|giv[66]	_	_
6-42	1295-1296	.	_	_	_	_

#Text=It can be envisioned that local changes in pH within a tissue microenvironment may modify the surface charge of landscape phage particles , exposing a previously hidden binding epitope or also hiding a previously accessible binding epitope allowing enhanced penetration or retention within a particular microenvironment .
7-1	1297-1299	It	abstract	giv	_	_
7-2	1300-1303	can	_	_	_	_
7-3	1304-1306	be	_	_	_	_
7-4	1307-1317	envisioned	_	_	_	_
7-5	1318-1322	that	_	_	_	_
7-6	1323-1328	local	abstract[68]	giv[68]	_	_
7-7	1329-1336	changes	abstract[68]	giv[68]	_	_
7-8	1337-1339	in	abstract[68]	giv[68]	_	_
7-9	1340-1342	pH	abstract[68]|abstract	giv[68]|new	_	_
7-10	1343-1349	within	abstract[68]	giv[68]	_	_
7-11	1350-1351	a	abstract[68]|abstract[71]	giv[68]|giv[71]	coref	7-44[81_71]
7-12	1352-1358	tissue	abstract[68]|object|abstract[71]	giv[68]|new|giv[71]	coref	10-10
7-13	1359-1375	microenvironment	abstract[68]|abstract[71]	giv[68]|giv[71]	_	_
7-14	1376-1379	may	_	_	_	_
7-15	1380-1386	modify	_	_	_	_
7-16	1387-1390	the	abstract[73]	giv[73]	coref	8-19[89_73]
7-17	1391-1398	surface	place|abstract[73]	giv|giv[73]	coref	8-22
7-18	1399-1405	charge	abstract[73]	giv[73]	_	_
7-19	1406-1408	of	abstract[73]	giv[73]	_	_
7-20	1409-1418	landscape	abstract[73]|object[75]	giv[73]|giv[75]	coref	9-25[106_75]
7-21	1419-1424	phage	abstract[73]|place|object[75]	giv[73]|giv|giv[75]	coref	9-4
7-22	1425-1434	particles	abstract[73]|object[75]	giv[73]|giv[75]	_	_
7-23	1435-1436	,	_	_	_	_
7-24	1437-1445	exposing	_	_	_	_
7-25	1446-1447	a	abstract[76]	new[76]	coref	7-33[78_76]
7-26	1448-1458	previously	abstract[76]	new[76]	_	_
7-27	1459-1465	hidden	abstract[76]	new[76]	_	_
7-28	1466-1473	binding	abstract[76]	new[76]	_	_
7-29	1474-1481	epitope	abstract[76]	new[76]	_	_
7-30	1482-1484	or	_	_	_	_
7-31	1485-1489	also	_	_	_	_
7-32	1490-1496	hiding	_	_	_	_
7-33	1497-1498	a	abstract[78]	giv[78]	_	_
7-34	1499-1509	previously	abstract[78]	giv[78]	_	_
7-35	1510-1520	accessible	abstract[78]	giv[78]	_	_
7-36	1521-1528	binding	object|abstract[78]	giv|giv[78]	_	_
7-37	1529-1536	epitope	abstract[78]	giv[78]	_	_
7-38	1537-1545	allowing	_	_	_	_
7-39	1546-1554	enhanced	abstract[79]	new[79]	_	_
7-40	1555-1566	penetration	abstract[79]	new[79]	_	_
7-41	1567-1569	or	_	_	_	_
7-42	1570-1579	retention	abstract[80]	new[80]	_	_
7-43	1580-1586	within	abstract[80]	new[80]	_	_
7-44	1587-1588	a	abstract[80]|abstract[81]	new[80]|giv[81]	coref	9-43[112_81]
7-45	1589-1599	particular	abstract[80]|abstract[81]	new[80]|giv[81]	_	_
7-46	1600-1616	microenvironment	abstract[80]|abstract[81]	new[80]|giv[81]	_	_
7-47	1617-1618	.	_	_	_	_

#Text=Following an extensive meta-analysis study of nanoparticle biocompatibility in vivo , it was concluded that functional nanocarriers had a slightly negative surface charge , moderate to high solubility , and particle sizes in the range of ~100 – 200 nm in diameter .
8-1	1619-1628	Following	_	_	_	_
8-2	1629-1631	an	abstract[83]	giv[83]	coref	10-2[118_83]
8-3	1632-1641	extensive	abstract[83]	giv[83]	_	_
8-4	1642-1655	meta-analysis	abstract|abstract[83]	new|giv[83]	_	_
8-5	1656-1661	study	abstract[83]	giv[83]	_	_
8-6	1662-1664	of	abstract[83]	giv[83]	_	_
8-7	1665-1677	nanoparticle	abstract[83]|abstract[84]	giv[83]|new[84]	_	_
8-8	1678-1694	biocompatibility	abstract[83]|abstract[84]	giv[83]|new[84]	_	_
8-9	1695-1697	in	abstract[83]	giv[83]	_	_
8-10	1698-1702	vivo	abstract[83]|abstract	giv[83]|new	ana	8-12
8-11	1703-1704	,	_	_	_	_
8-12	1705-1707	it	abstract	giv	coref	15-7
8-13	1708-1711	was	_	_	_	_
8-14	1712-1721	concluded	_	_	_	_
8-15	1722-1726	that	_	_	_	_
8-16	1727-1737	functional	object[87]	new[87]	_	_
8-17	1738-1750	nanocarriers	object[87]	new[87]	_	_
8-18	1751-1754	had	_	_	_	_
8-19	1755-1756	a	abstract[89]	giv[89]	_	_
8-20	1757-1765	slightly	abstract[89]	giv[89]	_	_
8-21	1766-1774	negative	abstract[89]	giv[89]	_	_
8-22	1775-1782	surface	place|abstract[89]	giv|giv[89]	coref	9-14
8-23	1783-1789	charge	abstract[89]	giv[89]	_	_
8-24	1790-1791	,	_	_	_	_
8-25	1792-1800	moderate	substance[90]	new[90]	_	_
8-26	1801-1803	to	substance[90]	new[90]	_	_
8-27	1804-1808	high	substance[90]	new[90]	_	_
8-28	1809-1819	solubility	substance[90]	new[90]	_	_
8-29	1820-1821	,	_	_	_	_
8-30	1822-1825	and	_	_	_	_
8-31	1826-1834	particle	object|abstract[92]	giv|new[92]	coref	9-52
8-32	1835-1840	sizes	abstract[92]	new[92]	_	_
8-33	1841-1843	in	abstract[92]	new[92]	_	_
8-34	1844-1847	the	abstract[92]|abstract[93]	new[92]|new[93]	_	_
8-35	1848-1853	range	abstract[92]|abstract[93]	new[92]|new[93]	_	_
8-36	1854-1856	of	abstract[92]|abstract[93]	new[92]|new[93]	_	_
8-37	1857-1861	~100	abstract[92]|abstract[93]|abstract[94]	new[92]|new[93]|new[94]	_	_
8-38	1862-1863	–	abstract[92]|abstract[93]|abstract[94]	new[92]|new[93]|new[94]	_	_
8-39	1864-1867	200	abstract[92]|abstract[93]|abstract[94]	new[92]|new[93]|new[94]	_	_
8-40	1868-1870	nm	abstract[92]|abstract[93]|abstract[94]	new[92]|new[93]|new[94]	_	_
8-41	1871-1873	in	abstract[92]|abstract[93]|abstract[94]	new[92]|new[93]|new[94]	_	_
8-42	1874-1882	diameter	abstract[92]|abstract[93]|abstract[94]|abstract	new[92]|new[93]|new[94]|new	_	_
8-43	1883-1884	.	_	_	_	_

#Text=Given that landscape phage libraries display peptide fusions that can dramatically alter the surface profile of the phage , we hypothesized that libraries of phage particles represent ideal nanoparticle systems to test the effects of a displayed peptide on tissue-selective accumulation within the local microenvironment while maintaining other critical parameters like particle size and shape .
9-1	1885-1890	Given	_	_	_	_
9-2	1891-1895	that	_	_	_	_
9-3	1896-1905	landscape	abstract[97]	giv[97]	coref	9-23[104_97]
9-4	1906-1911	phage	place|abstract[97]	giv|giv[97]	coref	9-17[102_0]
9-5	1912-1921	libraries	abstract[97]	giv[97]	_	_
9-6	1922-1929	display	_	_	_	_
9-7	1930-1937	peptide	substance|event[99]	giv|new[99]	coref	9-36[110_0]
9-8	1938-1945	fusions	event[99]	new[99]	_	_
9-9	1946-1950	that	event[99]	new[99]	_	_
9-10	1951-1954	can	event[99]	new[99]	_	_
9-11	1955-1967	dramatically	event[99]	new[99]	_	_
9-12	1968-1973	alter	event[99]	new[99]	_	_
9-13	1974-1977	the	event[99]|abstract[101]	new[99]|new[101]	_	_
9-14	1978-1985	surface	event[99]|place|abstract[101]	new[99]|giv|new[101]	_	_
9-15	1986-1993	profile	event[99]|abstract[101]	new[99]|new[101]	_	_
9-16	1994-1996	of	event[99]|abstract[101]	new[99]|new[101]	_	_
9-17	1997-2000	the	event[99]|abstract[101]|place[102]	new[99]|new[101]|giv[102]	coref	9-25[0_102]
9-18	2001-2006	phage	event[99]|abstract[101]|place[102]	new[99]|new[101]|giv[102]	_	_
9-19	2007-2008	,	_	_	_	_
9-20	2009-2011	we	person	giv	ana	10-2
9-21	2012-2024	hypothesized	_	_	_	_
9-22	2025-2029	that	_	_	_	_
9-23	2030-2039	libraries	abstract[104]	giv[104]	coref	10-16[123_104]
9-24	2040-2042	of	abstract[104]	giv[104]	_	_
9-25	2043-2048	phage	abstract[104]|place|object[106]	giv[104]|giv|giv[106]	coref	17-23
9-26	2049-2058	particles	abstract[104]|object[106]	giv[104]|giv[106]	_	_
9-27	2059-2068	represent	_	_	_	_
9-28	2069-2074	ideal	abstract[108]	new[108]	_	_
9-29	2075-2087	nanoparticle	abstract|abstract[108]	new|new[108]	_	_
9-30	2088-2095	systems	abstract[108]	new[108]	_	_
9-31	2096-2098	to	abstract[108]	new[108]	_	_
9-32	2099-2103	test	abstract[108]	new[108]	_	_
9-33	2104-2107	the	abstract[108]|abstract[109]	new[108]|new[109]	_	_
9-34	2108-2115	effects	abstract[108]|abstract[109]	new[108]|new[109]	_	_
9-35	2116-2118	of	abstract[108]|abstract[109]	new[108]|new[109]	_	_
9-36	2119-2120	a	abstract[108]|abstract[109]|substance[110]	new[108]|new[109]|giv[110]	coref	14-17[0_110]
9-37	2121-2130	displayed	abstract[108]|abstract[109]|substance[110]	new[108]|new[109]|giv[110]	_	_
9-38	2131-2138	peptide	abstract[108]|abstract[109]|substance[110]	new[108]|new[109]|giv[110]	_	_
9-39	2139-2141	on	abstract[108]|abstract[109]|substance[110]	new[108]|new[109]|giv[110]	_	_
9-40	2142-2158	tissue-selective	abstract[108]|abstract[109]|substance[110]|abstract[111]	new[108]|new[109]|giv[110]|new[111]	coref	10-10[122_111]
9-41	2159-2171	accumulation	abstract[108]|abstract[109]|substance[110]|abstract[111]	new[108]|new[109]|giv[110]|new[111]	_	_
9-42	2172-2178	within	abstract[108]|abstract[109]|substance[110]|abstract[111]	new[108]|new[109]|giv[110]|new[111]	_	_
9-43	2179-2182	the	abstract[108]|abstract[109]|substance[110]|abstract[111]|abstract[112]	new[108]|new[109]|giv[110]|new[111]|giv[112]	coref	18-77[209_112]
9-44	2183-2188	local	abstract[108]|abstract[109]|substance[110]|abstract[111]|abstract[112]	new[108]|new[109]|giv[110]|new[111]|giv[112]	_	_
9-45	2189-2205	microenvironment	abstract[108]|abstract[109]|substance[110]|abstract[111]|abstract[112]	new[108]|new[109]|giv[110]|new[111]|giv[112]	_	_
9-46	2206-2211	while	_	_	_	_
9-47	2212-2223	maintaining	_	_	_	_
9-48	2224-2229	other	abstract[113]	new[113]	_	_
9-49	2230-2238	critical	abstract[113]	new[113]	_	_
9-50	2239-2249	parameters	abstract[113]	new[113]	_	_
9-51	2250-2254	like	abstract[113]	new[113]	_	_
9-52	2255-2263	particle	abstract[113]|object|abstract[115]	new[113]|giv|new[115]	_	_
9-53	2264-2268	size	abstract[113]|abstract[115]	new[113]|new[115]	_	_
9-54	2269-2272	and	abstract[113]	new[113]	_	_
9-55	2273-2278	shape	abstract[113]|abstract	new[113]|new	_	_
9-56	2279-2280	.	_	_	_	_

#Text=In our study , we observed similar trends of tissue accumulation as reported previously for p3-type libraries .
10-1	2281-2283	In	_	_	_	_
10-2	2284-2287	our	person|abstract[118]	giv|giv[118]	ana	10-5
10-3	2288-2293	study	abstract[118]	giv[118]	_	_
10-4	2294-2295	,	_	_	_	_
10-5	2296-2298	we	person	giv	ana	12-1
10-6	2299-2307	observed	_	_	_	_
10-7	2308-2315	similar	abstract[120]	new[120]	_	_
10-8	2316-2322	trends	abstract[120]	new[120]	_	_
10-9	2323-2325	of	abstract[120]	new[120]	_	_
10-10	2326-2332	tissue	abstract[120]|object|abstract[122]	new[120]|giv|giv[122]	coref|coref	11-6[126_0]|14-25[147_122]
10-11	2333-2345	accumulation	abstract[120]|abstract[122]	new[120]|giv[122]	_	_
10-12	2346-2348	as	_	_	_	_
10-13	2349-2357	reported	_	_	_	_
10-14	2358-2368	previously	_	_	_	_
10-15	2369-2372	for	_	_	_	_
10-16	2373-2380	p3-type	abstract[123]	giv[123]	coref	17-22[181_123]
10-17	2381-2390	libraries	abstract[123]	giv[123]	_	_
10-18	2391-2392	.	_	_	_	_

#Text=Analysis of 3-mer frequency in each tissue revealed that a significant portion of motifs were shared across all tissues , leading to nonspecific uptake and clearance or had very low occurrences .
11-1	2393-2401	Analysis	abstract[124]	new[124]	_	_
11-2	2402-2404	of	abstract[124]	new[124]	_	_
11-3	2405-2410	3-mer	abstract[124]|abstract[125]	new[124]|new[125]	_	_
11-4	2411-2420	frequency	abstract[124]|abstract[125]	new[124]|new[125]	_	_
11-5	2421-2423	in	abstract[124]|abstract[125]	new[124]|new[125]	_	_
11-6	2424-2428	each	abstract[124]|abstract[125]|object[126]	new[124]|new[125]|giv[126]	coref	14-25[0_126]
11-7	2429-2435	tissue	abstract[124]|abstract[125]|object[126]	new[124]|new[125]|giv[126]	_	_
11-8	2436-2444	revealed	_	_	_	_
11-9	2445-2449	that	_	_	_	_
11-10	2450-2451	a	abstract[127]	new[127]	_	_
11-11	2452-2463	significant	abstract[127]	new[127]	_	_
11-12	2464-2471	portion	abstract[127]	new[127]	_	_
11-13	2472-2474	of	abstract[127]	new[127]	_	_
11-14	2475-2481	motifs	abstract[127]|abstract	new[127]|new	coref	12-9
11-15	2482-2486	were	_	_	_	_
11-16	2487-2493	shared	_	_	_	_
11-17	2494-2500	across	_	_	_	_
11-18	2501-2504	all	object[129]	new[129]	coref	18-24[193_129]
11-19	2505-2512	tissues	object[129]	new[129]	_	_
11-20	2513-2514	,	_	_	_	_
11-21	2515-2522	leading	_	_	_	_
11-22	2523-2525	to	_	_	_	_
11-23	2526-2537	nonspecific	abstract[130]	new[130]	_	_
11-24	2538-2544	uptake	abstract[130]	new[130]	_	_
11-25	2545-2548	and	_	_	_	_
11-26	2549-2558	clearance	event	new	_	_
11-27	2559-2561	or	_	_	_	_
11-28	2562-2565	had	_	_	_	_
11-29	2566-2570	very	event[132]	new[132]	_	_
11-30	2571-2574	low	event[132]	new[132]	_	_
11-31	2575-2586	occurrences	event[132]	new[132]	_	_
11-32	2587-2588	.	_	_	_	_

#Text=We were able to identify several families of motifs that were enriched in a tissue-selective manner .
12-1	2589-2591	We	person	giv	ana	14-3
12-2	2592-2596	were	_	_	_	_
12-3	2597-2601	able	_	_	_	_
12-4	2602-2604	to	_	_	_	_
12-5	2605-2613	identify	_	_	_	_
12-6	2614-2621	several	abstract[134]	new[134]	_	_
12-7	2622-2630	families	abstract[134]	new[134]	_	_
12-8	2631-2633	of	abstract[134]	new[134]	_	_
12-9	2634-2640	motifs	abstract[134]|abstract	new[134]|giv	coref	13-3[138_0]
12-10	2641-2645	that	abstract[134]	new[134]	_	_
12-11	2646-2650	were	abstract[134]	new[134]	_	_
12-12	2651-2659	enriched	abstract[134]	new[134]	_	_
12-13	2660-2662	in	abstract[134]	new[134]	_	_
12-14	2663-2664	a	abstract[134]|abstract[136]	new[134]|new[136]	ana	13-1[137_136]
12-15	2665-2681	tissue-selective	abstract[134]|abstract[136]	new[134]|new[136]	_	_
12-16	2682-2688	manner	abstract[134]|abstract[136]	new[134]|new[136]	_	_
12-17	2689-2690	.	_	_	_	_

#Text=Some of the identified motifs corresponded with previously identified tissue-selective motifs .
13-1	2691-2695	Some	abstract[137]	giv[137]	_	_
13-2	2696-2698	of	abstract[137]	giv[137]	_	_
13-3	2699-2702	the	abstract[137]|abstract[138]	giv[137]|giv[138]	coref	13-8[139_138]
13-4	2703-2713	identified	abstract[137]|abstract[138]	giv[137]|giv[138]	_	_
13-5	2714-2720	motifs	abstract[137]|abstract[138]	giv[137]|giv[138]	_	_
13-6	2721-2733	corresponded	_	_	_	_
13-7	2734-2738	with	_	_	_	_
13-8	2739-2749	previously	abstract[139]	giv[139]	coref	14-5[141_139]
13-9	2750-2760	identified	abstract[139]	giv[139]	_	_
13-10	2761-2777	tissue-selective	abstract[139]	giv[139]	_	_
13-11	2778-2784	motifs	abstract[139]	giv[139]	_	_
13-12	2785-2786	.	_	_	_	_

#Text=However , we identified many motifs that were not reported , suggesting that the type of peptide display will have a significant effect on tissue accumulation or pharmacokinetics .
14-1	2787-2794	However	_	_	_	_
14-2	2795-2796	,	_	_	_	_
14-3	2797-2799	we	person	giv	ana	15-5
14-4	2800-2810	identified	_	_	_	_
14-5	2811-2815	many	abstract[141]	giv[141]	coref	18-15[190_141]
14-6	2816-2822	motifs	abstract[141]	giv[141]	_	_
14-7	2823-2827	that	abstract[141]	giv[141]	_	_
14-8	2828-2832	were	abstract[141]	giv[141]	_	_
14-9	2833-2836	not	abstract[141]	giv[141]	_	_
14-10	2837-2845	reported	abstract[141]	giv[141]	_	_
14-11	2846-2847	,	_	_	_	_
14-12	2848-2858	suggesting	_	_	_	_
14-13	2859-2863	that	_	_	_	_
14-14	2864-2867	the	abstract[142]	new[142]	_	_
14-15	2868-2872	type	abstract[142]	new[142]	_	_
14-16	2873-2875	of	abstract[142]	new[142]	_	_
14-17	2876-2883	peptide	abstract[142]|substance|object[144]	new[142]|giv|new[144]	coref	17-25
14-18	2884-2891	display	abstract[142]|object[144]	new[142]|new[144]	_	_
14-19	2892-2896	will	_	_	_	_
14-20	2897-2901	have	_	_	_	_
14-21	2902-2903	a	abstract[145]	new[145]	_	_
14-22	2904-2915	significant	abstract[145]	new[145]	_	_
14-23	2916-2922	effect	abstract[145]	new[145]	_	_
14-24	2923-2925	on	abstract[145]	new[145]	_	_
14-25	2926-2932	tissue	abstract[145]|object|abstract[147]	new[145]|giv|giv[147]	coref|coref	15-29|27-33[262_147]
14-26	2933-2945	accumulation	abstract[145]|abstract[147]	new[145]|giv[147]	_	_
14-27	2946-2948	or	abstract[145]	new[145]	_	_
14-28	2949-2965	pharmacokinetics	abstract[145]|abstract	new[145]|new	_	_
14-29	2966-2967	.	_	_	_	_

#Text=The underlying hypothesis in our in vivo evolution study of landscape phages is based on the assumption that tissue-specific gene expression provides a context-dependent pathway for development of tissue specificity .
15-1	2968-2971	The	abstract[149]	new[149]	coref	18-4[186_149]
15-2	2972-2982	underlying	abstract[149]	new[149]	_	_
15-3	2983-2993	hypothesis	abstract[149]	new[149]	_	_
15-4	2994-2996	in	abstract[149]	new[149]	_	_
15-5	2997-3000	our	abstract[149]|person|abstract[153]	new[149]|giv|new[153]	ana	18-7
15-6	3001-3003	in	abstract[149]|abstract[153]	new[149]|new[153]	_	_
15-7	3004-3008	vivo	abstract[149]|abstract|abstract[153]	new[149]|giv|new[153]	coref	17-18
15-8	3009-3018	evolution	abstract[149]|event|abstract[153]	new[149]|giv|new[153]	_	_
15-9	3019-3024	study	abstract[149]|abstract[153]	new[149]|new[153]	_	_
15-10	3025-3027	of	abstract[149]|abstract[153]	new[149]|new[153]	_	_
15-11	3028-3037	landscape	abstract[149]|abstract[153]|abstract|animal[155]	new[149]|new[153]|giv|giv[155]	coref|coref	17-30[182_0]|27-36[0_155]
15-12	3038-3044	phages	abstract[149]|abstract[153]|animal[155]	new[149]|new[153]|giv[155]	_	_
15-13	3045-3047	is	_	_	_	_
15-14	3048-3053	based	_	_	_	_
15-15	3054-3056	on	_	_	_	_
15-16	3057-3060	the	abstract[156]	new[156]	_	_
15-17	3061-3071	assumption	abstract[156]	new[156]	_	_
15-18	3072-3076	that	abstract[156]	new[156]	_	_
15-19	3077-3092	tissue-specific	abstract[156]|abstract[158]	new[156]|giv[158]	coref	16-3[164_158]
15-20	3093-3097	gene	abstract[156]|abstract|abstract[158]	new[156]|giv|giv[158]	coref	16-3
15-21	3098-3108	expression	abstract[156]|abstract[158]	new[156]|giv[158]	_	_
15-22	3109-3117	provides	abstract[156]	new[156]	_	_
15-23	3118-3119	a	abstract[156]|abstract[159]	new[156]|new[159]	_	_
15-24	3120-3137	context-dependent	abstract[156]|abstract[159]	new[156]|new[159]	_	_
15-25	3138-3145	pathway	abstract[156]|abstract[159]	new[156]|new[159]	_	_
15-26	3146-3149	for	abstract[156]|abstract[159]	new[156]|new[159]	_	_
15-27	3150-3161	development	abstract[156]|abstract[159]|event[160]	new[156]|new[159]|new[160]	_	_
15-28	3162-3164	of	abstract[156]|abstract[159]|event[160]	new[156]|new[159]|new[160]	_	_
15-29	3165-3171	tissue	abstract[156]|abstract[159]|event[160]|object|abstract[162]	new[156]|new[159]|new[160]|giv|new[162]	coref	19-16
15-30	3172-3183	specificity	abstract[156]|abstract[159]|event[160]|abstract[162]	new[156]|new[159]|new[160]|new[162]	_	_
15-31	3184-3185	.	_	_	_	_

#Text=These tissue-specific gene expression profiles provide transcriptional and translational control for tissue-specific synthesis of corresponding proteins and their underlying protein-domain networks .
16-1	3186-3191	These	abstract[165]	new[165]	coref	18-64[205_165]
16-2	3192-3207	tissue-specific	abstract[165]	new[165]	_	_
16-3	3208-3212	gene	abstract|abstract[164]|abstract[165]	giv|giv[164]|new[165]	coref|coref	18-65|18-66[0_164]
16-4	3213-3223	expression	abstract[164]|abstract[165]	giv[164]|new[165]	_	_
16-5	3224-3232	profiles	abstract[165]	new[165]	_	_
16-6	3233-3240	provide	_	_	_	_
16-7	3241-3256	transcriptional	abstract[166]	new[166]	ana	17-1[0_166]
16-8	3257-3260	and	abstract[166]	new[166]	_	_
16-9	3261-3274	translational	abstract[166]	new[166]	_	_
16-10	3275-3282	control	abstract[166]	new[166]	_	_
16-11	3283-3286	for	abstract[166]	new[166]	_	_
16-12	3287-3302	tissue-specific	abstract[166]|event[167]	new[166]|new[167]	_	_
16-13	3303-3312	synthesis	abstract[166]|event[167]	new[166]|new[167]	_	_
16-14	3313-3315	of	abstract[166]|event[167]	new[166]|new[167]	_	_
16-15	3316-3329	corresponding	abstract[166]|event[167]|substance[168]|substance[169]	new[166]|new[167]|giv[168]|giv[169]	coref|ana	16-15[169_168]|16-18[0_169]
16-16	3330-3338	proteins	abstract[166]|event[167]|substance[168]|substance[169]	new[166]|new[167]|giv[168]|giv[169]	_	_
16-17	3339-3342	and	abstract[166]|event[167]|substance[169]	new[166]|new[167]|giv[169]	_	_
16-18	3343-3348	their	abstract[166]|event[167]|substance[169]|substance|abstract[171]	new[166]|new[167]|giv[169]|giv|new[171]	coref	17-7[174_171]
16-19	3349-3359	underlying	abstract[166]|event[167]|substance[169]|abstract[171]	new[166]|new[167]|giv[169]|new[171]	_	_
16-20	3360-3374	protein-domain	abstract[166]|event[167]|substance[169]|abstract[171]	new[166]|new[167]|giv[169]|new[171]	_	_
16-21	3375-3383	networks	abstract[166]|event[167]|substance[169]|abstract[171]	new[166]|new[167]|giv[169]|new[171]	_	_
16-22	3384-3385	.	_	_	_	_

#Text=It was suggested that components of these protein-domain networks could be identified through in vitro or in vivo targeted evolution of EBU/SLiM-harboring phage displayed peptide libraries such as the multivalent landscape phage library used in this project .
17-1	3386-3388	It	abstract	giv	_	_
17-2	3389-3392	was	_	_	_	_
17-3	3393-3402	suggested	_	_	_	_
17-4	3403-3407	that	_	_	_	_
17-5	3408-3418	components	abstract[173]	new[173]	_	_
17-6	3419-3421	of	abstract[173]	new[173]	_	_
17-7	3422-3427	these	abstract[173]|abstract[174]	new[173]|giv[174]	_	_
17-8	3428-3442	protein-domain	abstract[173]|abstract[174]	new[173]|giv[174]	_	_
17-9	3443-3451	networks	abstract[173]|abstract[174]	new[173]|giv[174]	_	_
17-10	3452-3457	could	_	_	_	_
17-11	3458-3460	be	_	_	_	_
17-12	3461-3471	identified	_	_	_	_
17-13	3472-3479	through	_	_	_	_
17-14	3480-3482	in	organization[175]	new[175]	_	_
17-15	3483-3488	vitro	organization[175]	new[175]	_	_
17-16	3489-3491	or	_	_	_	_
17-17	3492-3494	in	_	_	_	_
17-18	3495-3499	vivo	abstract	giv	_	_
17-19	3500-3508	targeted	event[177]	new[177]	_	_
17-20	3509-3518	evolution	event[177]	new[177]	_	_
17-21	3519-3521	of	event[177]	new[177]	_	_
17-22	3522-3540	EBU/SLiM-harboring	event[177]|abstract|abstract[181]	new[177]|new|giv[181]	_	_
17-23	3541-3546	phage	event[177]|place|abstract[181]	new[177]|giv|giv[181]	coref	17-32
17-24	3547-3556	displayed	event[177]|abstract[181]	new[177]|giv[181]	_	_
17-25	3557-3564	peptide	event[177]|substance|abstract[181]	new[177]|giv|giv[181]	_	_
17-26	3565-3574	libraries	event[177]|abstract[181]	new[177]|giv[181]	_	_
17-27	3575-3579	such	event[177]|abstract[181]	new[177]|giv[181]	_	_
17-28	3580-3582	as	event[177]|abstract[181]	new[177]|giv[181]	_	_
17-29	3583-3586	the	event[177]|abstract[181]|abstract[184]	new[177]|giv[181]|giv[184]	_	_
17-30	3587-3598	multivalent	event[177]|abstract[181]|abstract[182]|abstract[184]	new[177]|giv[181]|giv[182]|giv[184]	_	_
17-31	3599-3608	landscape	event[177]|abstract[181]|abstract[182]|abstract[184]	new[177]|giv[181]|giv[182]|giv[184]	_	_
17-32	3609-3614	phage	event[177]|abstract[181]|place|abstract[184]	new[177]|giv[181]|giv|giv[184]	_	_
17-33	3615-3622	library	event[177]|abstract[181]|abstract[184]	new[177]|giv[181]|giv[184]	_	_
17-34	3623-3627	used	event[177]|abstract[181]|abstract[184]	new[177]|giv[181]|giv[184]	_	_
17-35	3628-3630	in	event[177]|abstract[181]|abstract[184]	new[177]|giv[181]|giv[184]	_	_
17-36	3631-3635	this	event[177]|abstract[181]|abstract[184]|abstract[185]	new[177]|giv[181]|giv[184]|new[185]	_	_
17-37	3636-3643	project	event[177]|abstract[181]|abstract[184]|abstract[185]	new[177]|giv[181]|giv[184]|new[185]	_	_
17-38	3644-3645	.	_	_	_	_

#Text=In accordance with this hypothesis , we identified the following three major types of EBU motifs : ( 1 ) motifs common for all tissues ; ( 2 ) motifs specific for organs with functionally related tissues and similar correlated patterns of co-expressed genes ; and ( 3 ) motifs unique to single tissues with unique functions , which may be related to tissue-specific gene expression profiles within the tissues or to specific physical features of the local microenvironment .
18-1	3646-3648	In	_	_	_	_
18-2	3649-3659	accordance	_	_	_	_
18-3	3660-3664	with	_	_	_	_
18-4	3665-3669	this	abstract[186]	giv[186]	_	_
18-5	3670-3680	hypothesis	abstract[186]	giv[186]	_	_
18-6	3681-3682	,	_	_	_	_
18-7	3683-3685	we	person	giv	ana	19-3
18-8	3686-3696	identified	_	_	_	_
18-9	3697-3700	the	abstract[188]	new[188]	appos	18-21[191_188]
18-10	3701-3710	following	abstract[188]	new[188]	_	_
18-11	3711-3716	three	abstract[188]	new[188]	_	_
18-12	3717-3722	major	abstract[188]	new[188]	_	_
18-13	3723-3728	types	abstract[188]	new[188]	_	_
18-14	3729-3731	of	abstract[188]	new[188]	_	_
18-15	3732-3735	EBU	abstract[188]|animal|abstract[190]	new[188]|new|giv[190]	coref	18-21[192_190]
18-16	3736-3742	motifs	abstract[188]|abstract[190]	new[188]|giv[190]	_	_
18-17	3743-3744	:	abstract[188]	new[188]	_	_
18-18	3745-3746	(	abstract[188]	new[188]	_	_
18-19	3747-3748	1	abstract[188]	new[188]	_	_
18-20	3749-3750	)	abstract[188]	new[188]	_	_
18-21	3751-3757	motifs	abstract[191]|abstract[192]	giv[191]|giv[192]	appos|coref	18-30[194_191]|23-17[241_192]
18-22	3758-3764	common	abstract[191]|abstract[192]	giv[191]|giv[192]	_	_
18-23	3765-3768	for	abstract[192]	giv[192]	_	_
18-24	3769-3772	all	abstract[192]|object[193]	giv[192]|giv[193]	coref	18-35[196_193]
18-25	3773-3780	tissues	abstract[192]|object[193]	giv[192]|giv[193]	_	_
18-26	3781-3782	;	abstract[192]	giv[192]	_	_
18-27	3783-3784	(	abstract[192]	giv[192]	_	_
18-28	3785-3786	2	abstract[192]	giv[192]	_	_
18-29	3787-3788	)	abstract[192]	giv[192]	_	_
18-30	3789-3795	motifs	abstract[192]|abstract[194]	giv[192]|giv[194]	coref	18-50[200_194]
18-31	3796-3804	specific	abstract[192]|abstract[194]	giv[192]|giv[194]	_	_
18-32	3805-3808	for	_	_	_	_
18-33	3809-3815	organs	object[195]	new[195]	coref	26-1[244_195]
18-34	3816-3820	with	object[195]	new[195]	_	_
18-35	3821-3833	functionally	object[195]|object[196]|object[197]	new[195]|giv[196]|giv[197]	coref|coref	18-35[197_196]|18-53[201_197]
18-36	3834-3841	related	object[195]|object[196]|object[197]	new[195]|giv[196]|giv[197]	_	_
18-37	3842-3849	tissues	object[195]|object[196]|object[197]	new[195]|giv[196]|giv[197]	_	_
18-38	3850-3853	and	object[195]|object[197]	new[195]|giv[197]	_	_
18-39	3854-3861	similar	object[195]|object[197]|abstract[198]	new[195]|giv[197]|new[198]	_	_
18-40	3862-3872	correlated	object[195]|object[197]|abstract[198]	new[195]|giv[197]|new[198]	_	_
18-41	3873-3881	patterns	object[195]|object[197]|abstract[198]	new[195]|giv[197]|new[198]	_	_
18-42	3882-3884	of	object[195]|object[197]|abstract[198]	new[195]|giv[197]|new[198]	_	_
18-43	3885-3897	co-expressed	object[195]|object[197]|abstract[198]|abstract[199]	new[195]|giv[197]|new[198]|new[199]	coref	21-16[221_199]
18-44	3898-3903	genes	object[195]|object[197]|abstract[198]|abstract[199]	new[195]|giv[197]|new[198]|new[199]	_	_
18-45	3904-3905	;	_	_	_	_
18-46	3906-3909	and	_	_	_	_
18-47	3910-3911	(	_	_	_	_
18-48	3912-3913	3	_	_	_	_
18-49	3914-3915	)	_	_	_	_
18-50	3916-3922	motifs	abstract[200]	giv[200]	coref	19-9[213_200]
18-51	3923-3929	unique	abstract[200]	giv[200]	_	_
18-52	3930-3932	to	abstract[200]	giv[200]	_	_
18-53	3933-3939	single	abstract[200]|object[201]	giv[200]|giv[201]	coref	18-69[207_201]
18-54	3940-3947	tissues	abstract[200]|object[201]	giv[200]|giv[201]	_	_
18-55	3948-3952	with	abstract[200]|object[201]	giv[200]|giv[201]	_	_
18-56	3953-3959	unique	abstract[200]|object[201]|abstract[202]	giv[200]|giv[201]|new[202]	coref	26-17[249_202]
18-57	3960-3969	functions	abstract[200]|object[201]|abstract[202]	giv[200]|giv[201]|new[202]	_	_
18-58	3970-3971	,	abstract[200]	giv[200]	_	_
18-59	3972-3977	which	abstract[200]	giv[200]	_	_
18-60	3978-3981	may	abstract[200]	giv[200]	_	_
18-61	3982-3984	be	abstract[200]	giv[200]	_	_
18-62	3985-3992	related	abstract[200]	giv[200]	_	_
18-63	3993-3995	to	abstract[200]	giv[200]	_	_
18-64	3996-4011	tissue-specific	abstract[200]|abstract[205]|abstract[206]	giv[200]|giv[205]|giv[206]	coref	18-64[206_205]
18-65	4012-4016	gene	abstract[200]|abstract|abstract[205]|abstract[206]	giv[200]|giv|giv[205]|giv[206]	coref	22-15
18-66	4017-4027	expression	abstract[200]|abstract|abstract[205]|abstract[206]	giv[200]|giv|giv[205]|giv[206]	coref	22-16
18-67	4028-4036	profiles	abstract[200]|abstract[205]|abstract[206]	giv[200]|giv[205]|giv[206]	_	_
18-68	4037-4043	within	abstract[200]|abstract[205]|abstract[206]	giv[200]|giv[205]|giv[206]	_	_
18-69	4044-4047	the	abstract[200]|abstract[205]|abstract[206]|object[207]	giv[200]|giv[205]|giv[206]|giv[207]	coref	22-10[230_207]
18-70	4048-4055	tissues	abstract[200]|abstract[205]|abstract[206]|object[207]	giv[200]|giv[205]|giv[206]|giv[207]	_	_
18-71	4056-4058	or	abstract[200]|abstract[206]	giv[200]|giv[206]	_	_
18-72	4059-4061	to	abstract[200]|abstract[206]	giv[200]|giv[206]	_	_
18-73	4062-4070	specific	abstract[200]|abstract[206]|abstract[208]	giv[200]|giv[206]|giv[208]	_	_
18-74	4071-4079	physical	abstract[200]|abstract[206]|abstract[208]	giv[200]|giv[206]|giv[208]	_	_
18-75	4080-4088	features	abstract[200]|abstract[206]|abstract[208]	giv[200]|giv[206]|giv[208]	_	_
18-76	4089-4091	of	abstract[200]|abstract[206]|abstract[208]	giv[200]|giv[206]|giv[208]	_	_
18-77	4092-4095	the	abstract[200]|abstract[206]|abstract[208]|abstract[209]	giv[200]|giv[206]|giv[208]|giv[209]	coref	26-12[248_209]
18-78	4096-4101	local	abstract[200]|abstract[206]|abstract[208]|abstract[209]	giv[200]|giv[206]|giv[208]|giv[209]	_	_
18-79	4102-4118	microenvironment	abstract[200]|abstract[206]|abstract[208]|abstract[209]	giv[200]|giv[206]|giv[208]|giv[209]	_	_
18-80	4119-4120	.	_	_	_	_

#Text=Here , we demonstrated that the frequencies of several 3-mer motifs are shared across all tissue types (
19-1	4121-4125	Here	_	_	_	_
19-2	4126-4127	,	_	_	_	_
19-3	4128-4130	we	person	giv	ana	27-3
19-4	4131-4143	demonstrated	_	_	_	_
19-5	4144-4148	that	_	_	_	_
19-6	4149-4152	the	abstract[211]	new[211]	_	_
19-7	4153-4164	frequencies	abstract[211]	new[211]	_	_
19-8	4165-4167	of	abstract[211]	new[211]	_	_
19-9	4168-4175	several	abstract[211]|abstract[213]	new[211]|giv[213]	coref	19-15[215_213]
19-10	4176-4181	3-mer	abstract[211]|animal|abstract[213]	new[211]|new|giv[213]	_	_
19-11	4182-4188	motifs	abstract[211]|abstract[213]	new[211]|giv[213]	_	_
19-12	4189-4192	are	_	_	_	_
19-13	4193-4199	shared	_	_	_	_
19-14	4200-4206	across	_	_	_	_
19-15	4207-4210	all	abstract[215]	giv[215]	coref	21-25[224_215]
19-16	4211-4217	tissue	object|abstract[215]	giv|giv[215]	coref	21-26
19-17	4218-4223	types	abstract[215]	giv[215]	_	_
19-18	4224-4225	(	_	_	_	_

#Text=Figure 5
20-1	4226-4232	Figure	abstract[216]	new[216]	coref	24-1[243_216]
20-2	4233-4234	5	abstract[216]	new[216]	_	_

#Text=A , black arrow ) and can be representative of interactions with protein products of “ housekeeping-like ” genes expressed at constant levels across all tissue types , such as those involved in metabolism .
21-1	4235-4236	A	_	_	_	_
21-2	4237-4238	,	_	_	_	_
21-3	4239-4244	black	object[217]	new[217]	ana	21-31[225_217]
21-4	4245-4250	arrow	object[217]	new[217]	_	_
21-5	4251-4252	)	_	_	_	_
21-6	4253-4256	and	_	_	_	_
21-7	4257-4260	can	_	_	_	_
21-8	4261-4263	be	_	_	_	_
21-9	4264-4278	representative	_	_	_	_
21-10	4279-4281	of	_	_	_	_
21-11	4282-4294	interactions	abstract[218]	giv[218]	_	_
21-12	4295-4299	with	abstract[218]	giv[218]	_	_
21-13	4300-4307	protein	abstract[218]|substance|substance[220]	giv[218]|new|new[220]	_	_
21-14	4308-4316	products	abstract[218]|substance[220]	giv[218]|new[220]	_	_
21-15	4317-4319	of	abstract[218]|substance[220]	giv[218]|new[220]	_	_
21-16	4320-4321	“	abstract[218]|substance[220]|abstract[221]	giv[218]|new[220]|giv[221]	coref	27-20[258_221]
21-17	4322-4339	housekeeping-like	abstract[218]|substance[220]|abstract[221]	giv[218]|new[220]|giv[221]	_	_
21-18	4340-4341	”	abstract[218]|substance[220]|abstract[221]	giv[218]|new[220]|giv[221]	_	_
21-19	4342-4347	genes	abstract[218]|substance[220]|abstract[221]	giv[218]|new[220]|giv[221]	_	_
21-20	4348-4357	expressed	abstract[218]|substance[220]|abstract[221]	giv[218]|new[220]|giv[221]	_	_
21-21	4358-4360	at	abstract[218]|substance[220]|abstract[221]	giv[218]|new[220]|giv[221]	_	_
21-22	4361-4369	constant	abstract[218]|substance[220]|abstract[221]|abstract[222]	giv[218]|new[220]|giv[221]|new[222]	_	_
21-23	4370-4376	levels	abstract[218]|substance[220]|abstract[221]|abstract[222]	giv[218]|new[220]|giv[221]|new[222]	_	_
21-24	4377-4383	across	abstract[218]|substance[220]|abstract[221]	giv[218]|new[220]|giv[221]	_	_
21-25	4384-4387	all	abstract[218]|substance[220]|abstract[221]|abstract[224]	giv[218]|new[220]|giv[221]|giv[224]	coref	23-9[0_224]
21-26	4388-4394	tissue	abstract[218]|substance[220]|abstract[221]|object|abstract[224]	giv[218]|new[220]|giv[221]|giv|giv[224]	_	_
21-27	4395-4400	types	abstract[218]|substance[220]|abstract[221]|abstract[224]	giv[218]|new[220]|giv[221]|giv[224]	_	_
21-28	4401-4402	,	abstract[218]|substance[220]|abstract[221]	giv[218]|new[220]|giv[221]	_	_
21-29	4403-4407	such	abstract[218]|substance[220]|abstract[221]	giv[218]|new[220]|giv[221]	_	_
21-30	4408-4410	as	abstract[218]|substance[220]|abstract[221]	giv[218]|new[220]|giv[221]	_	_
21-31	4411-4416	those	abstract[218]|substance[220]|abstract[221]|object[225]	giv[218]|new[220]|giv[221]|giv[225]	_	_
21-32	4417-4425	involved	abstract[218]|substance[220]|abstract[221]|object[225]	giv[218]|new[220]|giv[221]|giv[225]	_	_
21-33	4426-4428	in	abstract[218]|substance[220]|abstract[221]|object[225]	giv[218]|new[220]|giv[221]|giv[225]	_	_
21-34	4429-4439	metabolism	abstract[218]|substance[220]|abstract[221]|object[225]|abstract	giv[218]|new[220]|giv[221]|giv[225]|new	_	_
21-35	4440-4441	.	_	_	_	_

#Text=Similar patterns of motif enrichment could be identified in tissues with functionally-related roles and gene expression patterns .
22-1	4442-4449	Similar	abstract[227]	new[227]	coref	22-15[234_227]
22-2	4450-4458	patterns	abstract[227]	new[227]	_	_
22-3	4459-4461	of	abstract[227]	new[227]	_	_
22-4	4462-4467	motif	abstract[227]|abstract|abstract[229]	new[227]|new|new[229]	ana|coref	23-1[0_229]|27-5
22-5	4468-4478	enrichment	abstract[227]|abstract[229]	new[227]|new[229]	_	_
22-6	4479-4484	could	_	_	_	_
22-7	4485-4487	be	_	_	_	_
22-8	4488-4498	identified	_	_	_	_
22-9	4499-4501	in	_	_	_	_
22-10	4502-4509	tissues	object[230]	giv[230]	coref	23-24[242_230]
22-11	4510-4514	with	object[230]	giv[230]	_	_
22-12	4515-4535	functionally-related	object[230]|abstract[231]	giv[230]|new[231]	_	_
22-13	4536-4541	roles	object[230]|abstract[231]	giv[230]|new[231]	_	_
22-14	4542-4545	and	object[230]	giv[230]	_	_
22-15	4546-4550	gene	object[230]|abstract|abstract[234]	giv[230]|giv|giv[234]	coref	23-8[238_234]
22-16	4551-4561	expression	object[230]|abstract|abstract[234]	giv[230]|giv|giv[234]	_	_
22-17	4562-4570	patterns	object[230]|abstract[234]	giv[230]|giv[234]	_	_
22-18	4571-4572	.	_	_	_	_

#Text=This can be visualized by enrichment of similar motifs patterns between the liver and spleen with 25 significantly enriched motifs being shared between both tissues (
23-1	4573-4577	This	abstract	giv	coref	23-6[236_0]
23-2	4578-4581	can	_	_	_	_
23-3	4582-4584	be	_	_	_	_
23-4	4585-4595	visualized	_	_	_	_
23-5	4596-4598	by	_	_	_	_
23-6	4599-4609	enrichment	abstract[236]	giv[236]	coref	27-5[254_236]
23-7	4610-4612	of	abstract[236]	giv[236]	_	_
23-8	4613-4620	similar	abstract[236]|abstract[238]	giv[236]|giv[238]	_	_
23-9	4621-4627	motifs	abstract[236]|abstract|abstract[238]	giv[236]|giv|giv[238]	coref	26-7[246_0]
23-10	4628-4636	patterns	abstract[236]|abstract[238]	giv[236]|giv[238]	_	_
23-11	4637-4644	between	abstract[236]	giv[236]	_	_
23-12	4645-4648	the	abstract[236]|object[239]	giv[236]|new[239]	_	_
23-13	4649-4654	liver	abstract[236]|object[239]	giv[236]|new[239]	_	_
23-14	4655-4658	and	abstract[236]	giv[236]	_	_
23-15	4659-4665	spleen	abstract[236]|object	giv[236]|new	_	_
23-16	4666-4670	with	_	_	_	_
23-17	4671-4673	25	abstract[241]	giv[241]	coref	28-5[265_241]
23-18	4674-4687	significantly	abstract[241]	giv[241]	_	_
23-19	4688-4696	enriched	abstract[241]	giv[241]	_	_
23-20	4697-4703	motifs	abstract[241]	giv[241]	_	_
23-21	4704-4709	being	abstract[241]	giv[241]	_	_
23-22	4710-4716	shared	abstract[241]	giv[241]	_	_
23-23	4717-4724	between	abstract[241]	giv[241]	_	_
23-24	4725-4729	both	abstract[241]|object[242]	giv[241]|giv[242]	coref	27-8[255_242]
23-25	4730-4737	tissues	abstract[241]|object[242]	giv[241]|giv[242]	_	_
23-26	4738-4739	(	_	_	_	_

#Text=Figure 5
24-1	4740-4746	Figure	abstract[243]	giv[243]	_	_
24-2	4747-4748	5	abstract[243]	giv[243]	_	_

#Text=A ) .
25-1	4749-4750	A	_	_	_	_
25-2	4751-4752	)	_	_	_	_
25-3	4753-4754	.	_	_	_	_

#Text=These organs are expected to contain cell types or structures within the local microenvironment that have common biological functions , representing a theoretical construct for targeting to a multi-organ system .
26-1	4755-4760	These	object[244]	giv[244]	_	_
26-2	4761-4767	organs	object[244]	giv[244]	_	_
26-3	4768-4771	are	_	_	_	_
26-4	4772-4780	expected	_	_	_	_
26-5	4781-4783	to	_	_	_	_
26-6	4784-4791	contain	_	_	_	_
26-7	4792-4796	cell	object|abstract[246]	new|giv[246]	_	_
26-8	4797-4802	types	abstract[246]	giv[246]	_	_
26-9	4803-4805	or	_	_	_	_
26-10	4806-4816	structures	abstract[247]	new[247]	coref	27-26[260_247]
26-11	4817-4823	within	abstract[247]	new[247]	_	_
26-12	4824-4827	the	abstract[247]|abstract[248]	new[247]|giv[248]	coref	27-28[261_248]
26-13	4828-4833	local	abstract[247]|abstract[248]	new[247]|giv[248]	_	_
26-14	4834-4850	microenvironment	abstract[247]|abstract[248]	new[247]|giv[248]	_	_
26-15	4851-4855	that	abstract[247]|abstract[248]	new[247]|giv[248]	_	_
26-16	4856-4860	have	abstract[247]|abstract[248]	new[247]|giv[248]	_	_
26-17	4861-4867	common	abstract[247]|abstract[248]|abstract[249]	new[247]|giv[248]|giv[249]	_	_
26-18	4868-4878	biological	abstract[247]|abstract[248]|abstract[249]	new[247]|giv[248]|giv[249]	_	_
26-19	4879-4888	functions	abstract[247]|abstract[248]|abstract[249]	new[247]|giv[248]|giv[249]	_	_
26-20	4889-4890	,	_	_	_	_
26-21	4891-4903	representing	_	_	_	_
26-22	4904-4905	a	abstract[250]	new[250]	_	_
26-23	4906-4917	theoretical	abstract[250]	new[250]	_	_
26-24	4918-4927	construct	abstract[250]	new[250]	_	_
26-25	4928-4931	for	abstract[250]	new[250]	_	_
26-26	4932-4941	targeting	abstract[250]	new[250]	_	_
26-27	4942-4944	to	abstract[250]	new[250]	_	_
26-28	4945-4946	a	abstract[250]|abstract[251]	new[250]|new[251]	_	_
26-29	4947-4958	multi-organ	abstract[250]|abstract[251]	new[250]|new[251]	_	_
26-30	4959-4965	system	abstract[250]|abstract[251]	new[250]|new[251]	_	_
26-31	4966-4967	.	_	_	_	_

#Text=Finally , we demonstrated motif enrichment within single tissues , including the tumor xenograft , which suggests there are tissue-specific genes that are overexpressed or structures in the microenvironment that allow for tissue-selective accumulation of phages .
27-1	4968-4975	Finally	_	_	_	_
27-2	4976-4977	,	_	_	_	_
27-3	4978-4980	we	person	giv	_	_
27-4	4981-4993	demonstrated	_	_	_	_
27-5	4994-4999	motif	abstract|abstract[254]	giv|giv[254]	_	_
27-6	5000-5010	enrichment	abstract[254]	giv[254]	_	_
27-7	5011-5017	within	_	_	_	_
27-8	5018-5024	single	object[255]	giv[255]	_	_
27-9	5025-5032	tissues	object[255]	giv[255]	_	_
27-10	5033-5034	,	object[255]	giv[255]	_	_
27-11	5035-5044	including	object[255]	giv[255]	_	_
27-12	5045-5048	the	object[255]|abstract[257]	giv[255]|new[257]	_	_
27-13	5049-5054	tumor	object[255]|object|abstract[257]	giv[255]|new|new[257]	coref	28-17
27-14	5055-5064	xenograft	object[255]|abstract[257]	giv[255]|new[257]	_	_
27-15	5065-5066	,	object[255]	giv[255]	_	_
27-16	5067-5072	which	object[255]	giv[255]	_	_
27-17	5073-5081	suggests	object[255]	giv[255]	_	_
27-18	5082-5087	there	object[255]	giv[255]	_	_
27-19	5088-5091	are	object[255]	giv[255]	_	_
27-20	5092-5107	tissue-specific	abstract[258]|abstract[259]	giv[258]|giv[259]	coref	27-20[259_258]
27-21	5108-5113	genes	abstract[258]|abstract[259]	giv[258]|giv[259]	_	_
27-22	5114-5118	that	abstract[258]|abstract[259]	giv[258]|giv[259]	_	_
27-23	5119-5122	are	abstract[258]|abstract[259]	giv[258]|giv[259]	_	_
27-24	5123-5136	overexpressed	abstract[258]|abstract[259]	giv[258]|giv[259]	_	_
27-25	5137-5139	or	abstract[259]	giv[259]	_	_
27-26	5140-5150	structures	abstract[259]|abstract[260]	giv[259]|giv[260]	_	_
27-27	5151-5153	in	abstract[259]|abstract[260]	giv[259]|giv[260]	_	_
27-28	5154-5157	the	abstract[259]|abstract[260]|abstract[261]	giv[259]|giv[260]|giv[261]	coref	28-16[268_261]
27-29	5158-5174	microenvironment	abstract[259]|abstract[260]|abstract[261]	giv[259]|giv[260]|giv[261]	_	_
27-30	5175-5179	that	abstract[259]|abstract[260]	giv[259]|giv[260]	_	_
27-31	5180-5185	allow	abstract[259]|abstract[260]	giv[259]|giv[260]	_	_
27-32	5186-5189	for	abstract[259]|abstract[260]	giv[259]|giv[260]	_	_
27-33	5190-5206	tissue-selective	abstract[259]|abstract[260]|abstract[262]	giv[259]|giv[260]|giv[262]	ana	28-1[0_262]
27-34	5207-5219	accumulation	abstract[259]|abstract[260]|abstract[262]	giv[259]|giv[260]|giv[262]	_	_
27-35	5220-5222	of	abstract[259]|abstract[260]|abstract[262]	giv[259]|giv[260]|giv[262]	_	_
27-36	5223-5229	phages	abstract[259]|abstract[260]|abstract[262]|animal	giv[259]|giv[260]|giv[262]|giv	_	_
27-37	5230-5231	.	_	_	_	_

#Text=This is demonstrated by 3-mer motifs like “ MYW ” that are only enriched within the tumor microenvironment and suggested to play a role in selective binding of a tumor-specific marker .
28-1	5232-5236	This	abstract	giv	_	_
28-2	5237-5239	is	_	_	_	_
28-3	5240-5252	demonstrated	_	_	_	_
28-4	5253-5255	by	_	_	_	_
28-5	5256-5261	3-mer	abstract[265]	giv[265]	_	_
28-6	5262-5268	motifs	abstract[265]	giv[265]	_	_
28-7	5269-5273	like	abstract[265]	giv[265]	_	_
28-8	5274-5275	“	abstract[265]	giv[265]	_	_
28-9	5276-5279	MYW	abstract[265]|abstract	giv[265]|new	_	_
28-10	5280-5281	”	abstract[265]	giv[265]	_	_
28-11	5282-5286	that	abstract[265]	giv[265]	_	_
28-12	5287-5290	are	abstract[265]	giv[265]	_	_
28-13	5291-5295	only	abstract[265]	giv[265]	_	_
28-14	5296-5304	enriched	abstract[265]	giv[265]	_	_
28-15	5305-5311	within	abstract[265]	giv[265]	_	_
28-16	5312-5315	the	abstract[265]|abstract[268]	giv[265]|giv[268]	_	_
28-17	5316-5321	tumor	abstract[265]|object|abstract[268]	giv[265]|giv|giv[268]	_	_
28-18	5322-5338	microenvironment	abstract[265]|abstract[268]	giv[265]|giv[268]	_	_
28-19	5339-5342	and	abstract[265]	giv[265]	_	_
28-20	5343-5352	suggested	abstract[265]	giv[265]	_	_
28-21	5353-5355	to	abstract[265]	giv[265]	_	_
28-22	5356-5360	play	abstract[265]	giv[265]	_	_
28-23	5361-5362	a	abstract[265]|abstract[269]	giv[265]|new[269]	_	_
28-24	5363-5367	role	abstract[265]|abstract[269]	giv[265]|new[269]	_	_
28-25	5368-5370	in	abstract[265]|abstract[269]	giv[265]|new[269]	_	_
28-26	5371-5380	selective	abstract[265]|abstract[269]|object[270]	giv[265]|new[269]|new[270]	_	_
28-27	5381-5388	binding	abstract[265]|abstract[269]|object[270]	giv[265]|new[269]|new[270]	_	_
28-28	5389-5391	of	abstract[265]|abstract[269]|object[270]	giv[265]|new[269]|new[270]	_	_
28-29	5392-5393	a	abstract[265]|abstract[269]|object[270]|abstract[271]	giv[265]|new[269]|new[270]|new[271]	_	_
28-30	5394-5408	tumor-specific	abstract[265]|abstract[269]|object[270]|abstract[271]	giv[265]|new[269]|new[270]|new[271]	_	_
28-31	5409-5415	marker	abstract[265]|abstract[269]|object[270]|abstract[271]	giv[265]|new[269]|new[270]|new[271]	_	_
28-32	5416-5417	.	_	_	_	_
